ULKI Presents As a Therapeutic Target to Sensitize Resistant Acute Myeloid Leukemia Cells to Venetoclax

被引：0
|
作者：
Betz, Heather [1 ,2 ]
Jiang, Xiaoyan [1 ,2 ]
机构：
[1] BC Canc Res Ctr, Terry Fox Lab, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Med, Vancouver, BC, Canada
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-206028
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2776 / 2776
页数：1
相关论文
共 50 条
  • [21] mTOR, a new therapeutic target in acute myeloid leukemia
    Récher, C
    Dos Santos, C
    Demur, C
    Payrastre, B
    CELL CYCLE, 2005, 4 (11) : 1540 - 1549
  • [22] Mastl Is a New Therapeutic Target for Acute Myeloid Leukemia
    Chen, Fangli
    Liu, Ligen
    Chen, Huijie
    Wu, Yicheng
    Wang, Yuanqin
    Fu, Zhen
    Zhang, Tinghua
    Jiang, Xuewei
    Lu, Yingting
    Zhao, Limin
    Li, Jutang
    Yang, Li
    BLOOD, 2024, 144 : 5842 - 5842
  • [23] Venetoclax triggers sublethal apoptotic signaling in venetoclax-resistant acute myeloid leukemia cells and induces vulnerability to PARP inhibition and azacitidine
    Tambe, Mahesh
    Unterberger, Sarah
    Kriegbaum, Mette C.
    Vanttinen, Ida
    Olgac, Ezgi June
    Vaha-Koskela, Markus
    Kontro, Mika
    Wennerberg, Krister
    Heckman, Caroline A.
    CELL DEATH & DISEASE, 2024, 15 (10):
  • [24] MYC Pathway Upregulation Identified in Non-Responders to Hypomethylating Agents and Presents a Therapeutic Target in Acute Myeloid Leukemia
    Ragon, Brittany Knick
    Templeton, Margaret D.
    Seegers, Sara L.
    Chen, Jenny
    Yang, Hsih-Te
    Knight, Thomas G.
    Ai, Jing
    Copelan, Edward A.
    Avalos, Belinda
    Steuerwald, Nury M.
    Jin, Jian
    Wang, Gang Greg
    Park, Steven I.
    Patel, Jai N.
    Grunwald, Michael R.
    Druhan, Lawrence J.
    BLOOD, 2023, 142
  • [25] Isatin analogs potentiate the cytotoxicity of venetoclax in acute myeloid leukemia cells
    Golla, Upendarrao
    Patel, Satyam
    Hengst, Jeremy
    Annageldiyev, Charyguly
    Schramm, Joseph
    Amin, Shantu
    Desai, Dhimant
    Claxton, David
    Dovat, Sinisa
    Sharma, Arati
    CANCER RESEARCH, 2024, 84 (06)
  • [26] Targeting Abnormally Increased Expression of ULK1 Sensitizes Acute Myeloid Leukemia Resistant Cells to Venetoclax
    Betz, Heather
    Jiang, Xiaoyan
    BLOOD, 2023, 142
  • [27] Combined venetoclax and alvocidib in acute myeloid leukemia
    Bogenberger, James
    Whatcott, Clifford
    Hansen, Nanna
    Delman, Devora
    Shi, Chang-Xin
    Kim, Wontak
    Haws, Hillary
    Soh, Katherine
    Lee, Ye Sol
    Peterson, Peter
    Siddiqui-Jain, Adam
    Weitman, Steven
    Stewart, Keith
    Bearss, David
    Mesa, Ruben
    Warner, Steven
    Tibes, Raoul
    ONCOTARGET, 2017, 8 (63): : 107206 - 107222
  • [28] Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia
    DiNardo, Courtney D.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (02) : 82 - 83
  • [29] Prescription patterns of venetoclax in acute myeloid leukemia
    Ucciero, Andrealuna
    Traversa, Giuseppe
    Pisterna, Alessia
    Cardinali, Valeria
    Sciabolacci, Sofia
    Poloni, Antonella
    Capelli, Debora
    Gaidano, Gianluca
    Patriarca, Andrea
    Lunghi, Monia
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (04)
  • [30] Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
    Barbosa, Karina
    Deshpande, Aniruddha J.
    FRONTIERS IN ONCOLOGY, 2023, 13
12345